Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Second response from Hawk on Feb. licenses

It appears PTSC has decided that they will not discuss the MMP even in a general way to shareholders. The MMP is the only reason any of us are here. Shareholders understand that PTSC can't provide specific details of settlements, but that should not stop them from talking about general information regarding the MMP. If some of our general questions are not answered, then it would appear that PTSC is purposely keeping us in the dark.

All the best,

Steve

Share
New Message
Please login to post a reply